Background: TGF-␤1 activates RhoA and nuclear factor-B (NF-B), but the activation mechanism was not clearly elucidated. Results: IKK␥ disrupts RhoA-Rho guanine nucleotide dissociation inhibitor (RhoGDI) complex, facilitating GTP binding to RhoA, resulting in IKK␤ phosphorylation by ROCK. Conclusion: IKK␥ facilitates RhoA activation, which in turn activates NF-B. Significance: We found the new mechanism of IKK␥ to activate RhoA and NF-B by TGF-␤1.
factor (GDF) to disrupt RhoA-RhoGDI complex, is required for the activation of RhoA by GEFs. Signals from active Rho GTPases transmit to a variety of effector proteins, including Rho-associated coiled-coil forming serine/threonine kinase (ROCK), which is activated by RhoA, and p21-activated kinase, which is activated by Cdc42/Rac (7) .
Nuclear factor-B (NF-B) is a transcription factor that controls the expression of specific target genes, including cytokines, chemokines, cell adhesion molecules, and inducible enzymes to regulate inflammation, cancer, apoptosis, and several other physiological phenomena (8) . The NF-B family consists of p65 (RelA), RelB, c-Rel, NF-B1 (p105, precursor of p50), and NF-B2 (p100, precursor of p52) forming hetero-or homodimers. Two principal pathways of NF-B activation have been elucidated: the classical pathway and the alternative pathway. In the classical pathway, the IB kinase (IKK) complex consists of two catalytic subunits, IKK␣ (IKK1) and IKK␤ (IKK2), and a regulatory subunit, IKK␥ (also referred to as NEMO (NF-B essential modifier). When IKK␤ is activated by phosphorylation, it can then phosphorylate inhibitor of NF-B (IB), which is bound to NF-B. When the phosphorylated IB is ubiquitinated and degraded, NF-B dimer such as p65/p50, which is released from IB, is translocated into the nucleus, where it binds to and activates the transcription of specific target genes. In the alternative pathway, the activation of IKK␣ homodimer by phosphorylation induces p100 processing and the nuclear translocation of the RelB/p52 dimer (9) . Intriguingly, ubiquitination, as well as phosphorylation, is involved in the activation of IKK (10) .
It is noteworthy that Rho subfamily small GTPases are implicated in NF-B activation (11) (12) (13) (14) (15) . In addition, TGF-␤1 can rapidly activate Rho subfamily GTPases, including RhoA, Cdc42, and Rac1, depending on the cell lines (3, 16 -18) . Furthermore, TGF-␤1 induces the activation of NF-B signaling (3, 19, 20) leading to cell motility (16, 21) . Although the relevance of TGF-␤1, Rho GTPases, and NF-B has been reported in a variety of cells, the molecular mechanism of the activation of NF-B by TGF-␤1 via RhoA GTPase activation in macrophages has not been well elucidated (17) .
Therefore, we attempted to discover the underlying molecular mechanism how RhoA regulates NF-B or vice versa upon TGF-␤1. We found that IKK activates RhoA; IKK␥ binds to the RhoA-RhoGDI complex, facilitating the activation of RhoA, likely by disrupting the RhoA-RhoGDI complex. Thereafter, active RhoA-GTP and its downstream component ROCK phosphorylates IKK␤, which in turn phosphorylates IB and p65, thereby leading to NF-B activation.
EXPERIMENTAL PROCEDURES
Materials-BSA, MG132, leptomycin B, isopropyl-␤-D-thiogalactoside, Triton X-100, PMSF, the anti-actin antibody, 2Ј/3Ј-O-(N-methylanthraniloyl)guanosine-5Ј-(␥-thio) triphosphate triethylammonium salt (Mant-GTP), and CHAPS were purchased from Sigma. TGF-␤1 expressed in CHO cells and active ROCK (amino acids 17-535) were purchased from R&D Systems (Minneapolis, MN). Y27632 and HA1077, inhibitors of ROCK, were purchased from Calbiochem (La Jolla, CA). FBS was purchased from Invitrogen. Protein A-agarose beads were purchased from Pierce. DMEM-F12, penicillin, and streptomycin were purchased from Lonza (Walkersville, MD). Glutathione-Sepharose 4B beads were from Amersham Biosciences. Glutathione was purchased from Elpis Biotech (Daejoen, Korea). The anti-phospho-p65 (Ser-536), anti-phospho-IKK␣/␤ (Ser-180/Ser-181), anti-phospho-Smad3 (Ser-423/425), and phospho-TGF-␤-activated kinase 1 (TAK1) antibodies were purchased from Cell Signaling Technology (Beverly, MA), and the anti-IKK␥ antibody was purchased from BD Biosciences. The anti-IKK␣ and anti-IKK␤ antibodies were purchased from Upstate Biotechnology (Waltham, MA). The anti-RhoA, anti-p65, anti-IB, anti-Smad3, anti-phospho-IB␣ (Ser-32/36), anti-phosphomyosin light chain phosphatase and anti-TAK1 antibodies, and GST-IB were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The TAK inhibitor 5z-7-oxozeaenol was purchased from Tocris Bioscience (Ellisville, MO). BMS345541, an IKK␤ inhibitor, was purchased from Calbiochem. [ 35 S]GTP␥ and [␥-
32 P]ATP were purchased from the Institute of Isotopes Co., Ltd. (Budapest, Hungary). Recombinant Tat-C3 toxin was purified from Escherichia coli (17) . GST-Rho binding domain (RBD) of rhotekin (GST-rhotekin-RBD) beads were prepared from cultured E. coli or obtained from Pierce. Dbs from the Rho-GEF assay kit was purchased from Cytoskeleton (Denver, CO). Recombinant GST-His-IKK␤ expressed in Sf9 cells was purchased from Creative Biomat (Shirley, NY). The RhoA-pCDNA3.1 and RhoGDI-pCDNA3.1 constructs were purchased from the Missouri S&T cDNA Resource Center. The GST-RhoA and GSTRhoGDI constructs were prepared by subcloning the appropriate genes into a pGEX4T-1 vector using the EcoRI/XhoI sites. The pGEX4T-1-IKK␥ and pET-IKK␥ constructs were provided by Dr. J. Ashwell (National Cancer Institute), and RelA (p65) cFLAG-pCDNA3 was provided by Dr. S. Smale (University of California, Los Angeles) through the Addgene plasmid repository. GST-p65 was constructed by subcloning the appropriate genes into pGEX4T-1 using the EcoRI/XhoI sites.
Cell Culture, Fluorescence Microscopy, and Confocal MicroscopyThe RAW264.7 (mouse macrophage) cell line was cultured (22) ; if necessary, TGF-␤1 (5 ng/ml) was treated. HeLa cells were cultured in DMEM containing 10% FBS, 100 units/ml streptomycin, and 100 units/ml penicillin at 37°C in 5% CO 2 . The cells were fixed with 4% paraformaldehyde for 10 min, neutralized with 20 mM glycine for 10 min, and then washed three times with PBS containing 0.1% Triton X-100. The samples were incubated with primary antibody (1:100) overnight at 4°C, washed, and then incubated with the appropriate fluorescent dye-conjugated secondary antibody for 2 h at 24°C. DAPI (1 g/ml) was added 10 min before washing. Fluorescence was observed by fluorescence microscopy (Axiovert 200; Carl Zeiss; Göttingen, Germany) and confocal microscopy (LSM 780NLO; Carl Zeiss). RhoA was identified using an anti-RhoA antibody, which is recognized by an Alexa Fluor 488-conjugated secondary antibody (green), and IKK␥ was identified by an anti-IKK␥ antibody, which is recognized by an Alexa Flour 568-conjugated secondary antibody (red). Nuclei were identified with DAPI staining (blue).
Assay of Cell Migration-Migration of RAW264.7 cells was determined using a Transwell permeable support kit with polycarbonate filter (22) .
Luciferase Reporter Assays-RAW264.7 cells were grown to 80% confluence in six-well plates and then transiently transfected with the pNF-B-Luc cis reporter plasmid (Stratagene; Santa Clara, CA) by incubating with Lipofectamine 2000 (Invitrogen) or Attractene (Qiagen; Hilden, Germany) for 3 h according to the manufacturer's instructions. To calibrate the variation in transfection efficiency, the cells were co-transfected with 1 g of pCS2ϩ-␤-galactosidase plasmids, an expression plasmid for the E. coli galactosidase gene. The transfected cells were incubated in serum-free medium for 24 h, rinsed with PBS, lysed in 1ϫ reporter lysis buffer (Promega; Madison, WI), and the cell debris was removed by centrifugation. The relative luciferase activity of the supernatant was measured using a luminometer according to the manufacturer's instructions (Lumat LB 9057; EG & G Bertold).
Loading of GDP and GTP␥S onto GTP-binding Proteins in Vitro-Cell lysates (1 g/l protein in 500 l) were incubated with 10 mM EDTA, pH 8.0. Next, GTP␥S or GDP was added to the cell lysates to a final concentration of 0.1 or 1 mM, respectively, and incubated at 30°C for 30 min with constant agitation. The reaction was terminated by thoroughly mixing with MgCl 2 at a final concentration of 60 mM on ice. To determine the level of RhoA-GTP, GST-rhotekin-RBD beads (23) and an EZ-Detect Rho activation kit containing GST-RBD (Pierce) were used (24) .
Assay of GTP Binding to RhoA-RhoA in the absence or presence of RhoGDI or the RhoA-RhoGDI complex in buffer (10 mM HEPES, pH 7.4, 50 mM NaCl, 1 or 5 mM MgCl 2 , 2 or 1 mM EDTA, respectively, 1 mM DTT, 0.1% CHAPS) was incubated with [ 35 S]GTP␥ at 24°C for 30 min in the presence of IKK␥, Dbs (a GEF of RhoA), or CHAPS. The reaction was terminated by adding ice-cold stop buffer (10 mM HEPES, pH 7.5, 50 mM NaCl, 25 mM MgCl 2 ), filtered with a BA85 membrane (0.45 m; Schleicher & Schuell; Dassel, Germany), and washed twice with 2 ml of stop buffer. The radioactivity on the membrane, which corresponded to [ 35 S]GTP␥ bound with RhoA, was measured with a liquid scintillation counter (Beckman LS5801) (25) . Mant-GTP was incubated with RhoA in buffer (10 mM HEPES, pH 7.4, 50 mM NaCl, 1 mM MgCl 2 , 2 mM EDTA, 1 mM DTT, 0.1% CHAPS). Fluorescence was measured at an emission wavelength of 440 nm and an excitation wavelength of 360 nm using a fluorescence spectrophotometer (Spectra M2; Molecular Devices; Sunnyvale, CA).
Construction and Transient Transfection of a Small Hairpin RNA Targeting RhoA-A shRNA-expressing sequence for targeting RhoA mRNA was cloned into the pSUPER RNAi system (Oligoengine; Seattle, WA) (22, 26) .
Immunoprecipitation-Immunoprecipitation was performed according to the previous report (17 XhoI sites were introduced into the 5Ј and 3Ј ends, respectively. The GST-IKK␥ fusion protein was expressed in E. coli BL-21. To determine protein-protein binding, GST-IKK␥ beads and the proteins were incubated in a buffer (50 mM Tris-HCl, pH 7.5, 1ϫ PBS, 10% glycerol, and 1 g/ml each aprotinin, leupeptin, and pepstatin A and 1 mM PMSF) for 2 h at 4°C. After washing the beads, bound proteins were identified with Western blotting.
Purification of RhoA, RhoGDI, IKK␥, and p65-To generate the GST-RhoA, GST-RhoGDI, GST-IKK␥, and GST-p65 fusion proteins, E. coli were transformed with pGEX-4T-1 plasmids (Invitrogen) containing the RhoA, RhoGDI, IKK␥, and p65 genes, respectively. The GST tag was removed by cleavage with thrombin (27) . In some experiments, His-IKK␥ was purified using Ni 2ϩ -nitrilotriacetic acid beads (Novagen; Darmstadt, Germany). RhoA expressed in Sf9 cells harboring baculovirus containing cDNA encoding RhoA was purified (27) . RhoA from the cytosol and membrane were noted as C-RhoA and M-RhoA, respectively. The RhoA-RhoGDI complex was prepared by mixing and incubating RhoA and RhoGDI in buffer (10 mM HEPES, pH 7.5, 50 mM NaCl, 0.1 mM EDTA, 5 mM MgCl 2 , 5% glycerol, 1 mM DTT, 1 mM GDP, and protease inhibitors) for 1 h at 24°C. To remove the uncomplexed proteins (RhoA is ϳ22 kDa; RhoGDI is ϳ26 kDa) from RhoA-RhoGDI, which has an estimated molecular mass of 48 kDa, the solution was centrifuged using an ultrafiltration kit (Amicon Ultrafilter; cut-off size, 30 kDa). The concentrated solution was washed three times by adding 0.5 ml of dialysis buffer (10 mM HEPES, pH 7.5, 50 mM NaCl, 0.1 mM EDTA, 5 mM MgCl 2 , 2.5% glycerol, 1 mM DTT, and protease inhibitors). Finally, the protein complex was aliquoted and stored at Ϫ70°C until use.
Proximity Ligation Assay-To detect the interaction between RhoA and IKK, we utilized the DuoLink in situ proximity ligation assay (Olink Bioscience; Uppsala, Sweden) according to the manufacturer's protocol.
In Vitro Kinase Assay of ROCK-Cells were lysed in a 50-l lysis buffer (50 mM Tris-Cl, pH 7.5, 50 mM glycerophosphate, 150 mM NaCl, 10% glycerol, 1% Tween 20, 1 mM each of DTT, PMSF, NaF, and NaVO 4 , 1 g/ml each of leupeptin, aprotinin, and pepstatin A) containing 10 mM MgCl 2 and 25 M ATP. To determine direct phosphorylation of IKK␤ by ROCK, 100 ng of active ROCK1 (amino acids, aa 17-535) and 100 ng of recombinant IKK␤ were mixed in the presence or absence of cell lysates (50 g) and incubated for 30 min at 30°C in 40 l of a kinase assay buffer (10 mM HEPES, pH 7.5, 50 mM glycerophosphate, 50 mM NaCl, 10 mM MgCl 2 , 10 mM MnCl 2 , 1 mM DTT, 30 M ATP), and samples were incubated for 30 min at 30°C. Samples were analyzed by Western blot using IKK␣ (Ser-176)/ IKK␤ (Ser-177) and anti-phospho-IKK␣ (Ser-180)/IKK␤ (Ser-181) antibodies.
Measurement of MIP-1␣-Macrophage inflammatory protein (MIP)-1␣ secreted from the RAW264.7 cells in response to TGF-␤1 was quantitatively determined using ELISA (R&D Systems) according to the manufacturer's instructions. RAW264.7 cells were incubated with TGF-␤1 for various time periods. Reverse transcription PCR and real-time PCR for MIP-1␣ mRNA expression was performed according to the previous report (22) .
Statistical Analysis-Data are presented as the means Ϯ S.E. of at least three independent experiments. The Student's t test was used to compare groups using the GraphPad Prism program (San Diego, CA).
RESULTS

RhoA Interacts with the IKK Complex-TGF-␤1 increased
RhoA-GTP levels in a 30 -60-min treatment and then decreased (Fig. 1A) , which is accordance with the previous results (17) . Considering the relevance between RhoA and NF-B, we found that the amino acid sequence of IKK␥ is partially identical to RhoA effector proteins, including ROCK1, protein kinase N, rhophilin, and rhotekin although the homologous regions of IKK␥ are not identical with the known Rhobinding domains of the effector proteins (supplemental Fig. S1 ). Therefore, we examined the possible binding of RhoA to IKK␥. Immunoprecipitation of IKK␥ resulted in the co-precipitation of RhoA in a resting state, whereas TGF-␤1 reduced the co-precipitation of RhoA and IKK␥ (Fig. 1B) . In addition, RhoA was co-immunoprecipitated with IKK␣/␤ without TGF-␤1, but TGF-␤1 also reduced the amount of RhoA that was co-immunoprecipitated with IKK␣/␤ (Fig. 1B) . Whereas co-immunoprecipitation of RhoA with IKK␥ was reduced in 1 h treatment of TGF-␤1, their interaction was recovered after 24 h (Fig. 1C) . This suggests that RhoA-GDP instead of RhoA-GTP is preferentially bound to IKK␥.
In addition, the proximity ligation assay, which evaluates the interaction of two proteins in situ showed an interaction between RhoA and IKK␥ in a resting state, but TGF-␤1 markedly reduced the interaction between RhoA and IKK␥ (Fig. 1D) . Consistently, confocal microscopy showed the co-localization of RhoA and IKK␥ in HeLa cells. However, TGF-␤1 reduced the co-localization of RhoA and IKK␥; RhoA was instead translocated to the plasma membrane (Fig. 1E) . Notably, RhoA was observed in both the cytosol and nucleus of HeLa cells (Fig. 1E) . Furthermore, purified RhoA was bound with purified recombinant GST-IKK␥ in a concentration-dependent manner (Fig.  1F) , suggesting that RhoA directly interacts with IKK␥. A, RAW264.7 cells were incubated with 5 ng/ml TGF-␤1 at 37°C, and GTP-RhoA levels were determined. B, the cells were treated TGF-␤1 for 3 h. IKK␣/IKK␤ and IKK␥ were immunoprecipitated with an anti-IKK␥ antibody for 2 h at 4°C, and then their co-precipitation with RhoA was determined by Western blot. C, control; T, TGF-␤1 treatment. C, RAW264.7 cells were incubated with TGF-␤1, and IKK␥ was immunoprecipitated. The bound RhoA were analyzed by Western blot. Intensity of RhoA was quantified by densitometry (lower panel). D, RAW264.7 cells were treated with TGF-␤1 for 1 h, and the interaction between RhoA and IKK was visualized in situ using a proximity ligation assay (PLA). The results are given as the means Ϯ S.E. of three independent experiments (*, p Ͻ 0.05; **, p Ͻ 0.01; ***, p Ͻ 0.001). E, HeLa cells were treated with TGF-␤1 for 1 h, and RhoA (green), IKK␥ (red), and nuclei (blue) were visualized. Arrows indicate RhoA localization in the membrane. F, GST-IKK␥ (1 g of protein)-Sepharose 4B beads were incubated with 0.5-4 g of purified M-RhoA for 2 h at 4°C, and RhoA bound to GST-IKK␥ was detected by Western blot. The amount of RhoA bound to IKK␥ was calculated from the control standard curve. GST-IKK␥ was detected with Ponceau S staining. CON, control; IB, immunoblot.
RhoA-GDP and RhoGDI
Interact with IKK␥-To investigate whether the GDP-or GTP-bound state of RhoA affects its interaction with IKK␥, cell lysates were preincubated with GDP or GTP␥S, and immunoprecipitation was performed. RhoA underwent co-immunoprecipitation with IKK␥ in the presence of GDP, but the co-immunoprecipitation was markedly reduced in the presence of GTP␥S ( Fig. 2A) . Consistently, RhoA purified from the membranous (M-RhoA) and cytosolic (C-RhoA) fractions of Sf9 insect cells directly bound to GST-IKK␥ in its GDP-bound state, whereas RhoA-GTP␥S rarely interacted with GST-IKK␥ (Fig. 2B) . The recombinant RhoA-GDP purified from E. coli was able to bind to GST-IKK␥, instead RhoA-GTP␥S rarely bound to IKK␥ (Fig. 2C) , suggesting that prenyl group of RhoA is not essential for the binding to IKK␥.
Because cytosolic RhoA-GDP in a resting state was considered to form a complex with RhoGDI, we examined whether RhoGDI is also capable of binding to IKK␥. Indeed, cytosolic RhoGDI was bound to IKK␥ irrespective of the presence of either GDP or GTP␥S (Fig. 2D) . The purified RhoGDI directly bound to GST-IKK␥/glutathione-Sepharose beads in a concentration-dependent manner (Fig. 2E) . In addition, the RhoARhoGDI complex, as well as RhoA or RhoGDI alone, was bound to IKK␥, suggesting that a trimeric complex of RhoA-RhoGDI-IKK␥ is formed in vitro (Fig. 2F) . (Fig. 3A) . RhoA-GDP was bound to N-and C-terminal domains of IKK␥ (aa 1-43, 1-100, and 350 -419, respectively), but it was not bound to the large C-terminal domain (aa 44 -419) of IKK␥. Instead, RhoGDI was bound to C-terminal domains (aa 101-419) but not to the N-terminal domain (aa 1-111) (Fig. 3B) . Because zinc finger domain (aa 389 -419) in C-terminal region of IKK␥ was known to be a binding site of IB (28), the competition between FIGURE 2. RhoA and RhoGDI interact with IKK␥. A, RAW264.7 cell lysates were preloaded with 0.1 mM GTP␥S or 1 mM GDP for 30 min. The lysates were subjected to immunoprecipitation with an anti-IKK␥ antibody and analyzed by Western blot with the anti-RhoA and anti-IKK␥ antibodies. B, RhoA proteins purified from the membrane (M-RhoA) and cytosolic fractions (C-RhoA) of Sf9 cells, preloaded with 1 mM GDP or 0.1 mM GTP␥S, were precipitated with purified GST-IKK␥-Sepharose 4B beads. The GST and GST-IKK␥ levels were measured with Ponceau S staining. C, recombinant RhoA protein (1 g) expressed in E. coli was preloaded with 1 mM GDP or 0.1 mM GTP␥S and then precipitated with purified GST-IKK␥-Sepharose 4B beads. GST and GST-IKK␥ were identified with Ponceau S staining. The data represent the means Ϯ S.E. of three independent experiments (*, p Ͻ 0.05; **, p Ͻ 0.01; ***, p Ͻ 0.001). D, lysates of RAW264.7 cells (500 g of protein) were preloaded with 1 mM GDP and 0.1 mM GTP␥S for 30 min at 30°C. WCL, whole cell lysate. IKK␥ was immunoprecipitated using 2 g of anti-IKK␥ antibody for 2 h at 4°C. Co-precipitated RhoGDI was detected by Western blot analysis. E, 1 g of GST-IKK␥ conjugated to glutathione beads was incubated with 0.5-4 g of recombinant RhoGDI for 2 h at 4°C. RhoGDI bound to IKK␥ was detected by Western blot. The amount of RhoGDI bound to IKK␥ was calculated from the control standard curve. GST-IKK␥ was detected with Ponceau S staining. F, 1 g of GST-IKK␥ conjugated to glutathione beads (GSH) was incubated with 2 g of recombinant RhoA (R) purified from Sf9 cell membranes, 2 g of purified RhoGDI (G), and 2 g of purified RhoA-RhoGDI complex (C) for 2 h at 4°C. RhoA and RhoGDI bound to IKK␥ were detected by Western blot.
RhoA-GDP and RhoGDI Bind to Different Domains of IKK␥-
IB and RhoGDI for the binding toward IKK␥ was explored. High concentration of IB prevented RhoGDI from binding to IKK␥ in vitro (Fig. 3C) . Consistently, co-immunoprecipitation of IKK␥ with IB increased upon TGF-␤1 in the presence of MG132, an inhibitor of proteasomal degradation, and the coimmunoprecipitation of IKK␥ with RhoGDI was slightly reduced in cells (Fig. 3D) , suggesting that TGF-␤1 stimulates IB binding to IKK␥.
Similarly, because the N-terminal domain (aa 44 -111) was known to be a binding site of IKK␤ (29) , the competition between RhoA-GDP and IKK␤ was examined; high concentration of IKK␤ did not interfere with the binding of RhoA-GDP to IKK␥ (Fig. 3E) , suggesting that IKK␤ and RhoA-GDP do not compete each other for their binding to IKK␥. The proposed diagram of the interaction of the proteins was shown in Fig. 3F .
IKK␥ Facilitates the Activation of RhoA Complexed with RhoGDI in
Vitro-Herein, we inferred that IKK␥ could disrupt the interaction between RhoA and RhoGDI because RhoA-GDP bound to the N-terminal domain, and RhoGDI bound to the C-terminal domain of IKK␥, respectively. To demonstrate this hypothesis, we prepared purified proteins, including RhoA, RhoGDI, a complex of RhoA-RhoGDI, and IKK␥ (Fig. 4A) .
Next, we examined whether IKK␥ is able to facilitate the incorporation of GTP into RhoA in the complex of RhoA-RhoGDI. The preliminary experiment showed that the fluorescence intensity of 2Ј(3Ј)-O-(N-methylanthraniloyl) (Mant)-GTP (30, 31) was linearly correlated with RhoA concentration, suggesting that the extent of fluorescence presents the binding of Mant-GTP to RhoA. The fluorescence intensity of Mant-GTP bound to M-RhoA (Fig. 4B) and C-RhoA (data not shown) increased in a time-dependent manner, but RhoGDI interfered with the increase in Mant-GTP binding. However, IKK␥ significantly augmented the fluorescence of Mant-GTP by binding to RhoA complexed with RhoGDI (Fig. 4B) . However, IKK␥ could not augment the fluorescence of Mant-GTP-bound to RhoA alone (Fig. 4F) , suggesting that IKK␥ does not play a role as a GEF.
To confirm this result again, we measured the binding of [ 35 (Fig. 4, C and D) , which was in a concentration-dependent manner (Fig. 4E) . At a low MgCl 2 concentration, much more [
35 S]GTP␥ was incorporated into RhoA than at a high MgCl 2 concentration (Fig. 4E) . Furthermore, Dbs, a GEF for RhoA (13) much more enhanced the binding of [ 35 S]GTP␥ to RhoA complexed with RhoGDI in the presence of IKK␥ than in the absence of it (Fig. 4, C and D) . Here, the detergent CHAPS (1%) was used to disrupt the RhoA-RhoGDI complex. CHAPS seemed to impair Dbs activity, likely by preventing Dbs from acessing RhoA. Consistently, knockdown of IKK␥ by si-IKK␥ blocked the induction of RhoA-GTP in cells upon TGF-␤1 stimulation (Fig. 4G) , suggesting that IKK␥ is indispensable for RhoA activation by TGF-␤1.
RhoA Is Involved in NF-B Activation in Response to TGF-␤1-We tried to ascertain the involvement of RhoA in NF-B activation due to TGF-␤1. TGF-␤1 increased the NF-B reporter gene activity in 1 h, but its activity then decreased after 12-24 h (Fig. 5A) . However, both treatment with an IKK␤ inhibitor (BMS34551) and transfection of an IB super suppressor (SR, IB S32A/S36A) abolished NF-B activation by TGF-␤1 (Fig.  5B) . TGF-␤1 induced IB degradation, but this degradation was blocked by the proteasomal inhibitor MG132 (Fig. 5C) , suggesting that TGF-␤1 activates NF-B by degrading IB in the proteasome.
In addition, transfection of dominant-negative RhoA (T19N) (Fig. 5D) , treatment of Tat-C3 toxin (Fig. 5E) , and transfection of sh-RhoA (Fig. 5F ) reduced TGF-␤1-induced NF-B pro- moter fused luciferase activity, whereas transfection of WT RhoA and constitutively active RhoA (G14V) promoted this activity (Fig. 5D) . However, TGF-␤1 induced the phosphorylation of IKK␣/␤, IB␣, and p65. However, the depletion of RhoA by transfecting sh-RhoA into the cells inhibited the phosphorylation of IKK␣/␤, IB␣, and p65 (Fig. 5G) . These results suggest that RhoA is essential for NF-B activation in the TGF-␤1 signaling pathway in macrophages.
ROCK Is Involved in NF-B Activation-Furthermore, Y27632 and HA1077 (Fasudil), inhibitors of ROCK reduced the NF-B reporter gene luciferase activities by TGF-␤1 (Fig. 6A) . However, Y27632 did not alter the level of phosphorylated Smad3 in response to TGF-␤1 (data not shown), indicating that although TGF-␤1 can stimulates the Smad pathway, RhoA/ ROCK activation is not implicated in Smad activation. Moreover, Y27632 and 5z-7-oxozeaenol, a TAK1 inhibitor (32), prevented the degradation of IB, as well as the phosphorylation of IB, IKK␣/␤, and p65 by TGF-␤1 (Fig. 6B) , suggesting that ROCK and TAK1 are essential for NF-B activity in response to TGF-␤1. Thus, we clarified whether ROCK directly phosphorylates IKK␤. When the constitutively active form of ROCK (aa 17-535) lacking the C-terminal region of the Rho-binding domain (33) and recombinant GST-IKK␤ were incubated in the presence (Fig. 6D ) or in the absence of cytosol (Fig. 6C) , the phosphorylated IKK␤ was detected with anti-phospho-IKK␤ antibodies (Ser-177 and Ser-181), suggesting that ROCK FIGURE 5. TGF-␤1 induces RhoA-mediated NF-B activation. A, RAW 264.7 cells were co-transfected with a NF-B luciferase cis-reporter construct and a pCS2ϩ-␤-galactosidase plasmid, incubated for 24 h, and then stimulated with TGF-␤1. Luciferase activity was measured with a luminometer. B, cells were co-transfected with the NF-B luciferase reporter construct and pCS2ϩ-␤-galactosidase plasmids, or each 1 g/ml mock (M) vector and the IB␣ super repressor (S32A/S36A) DNA construct (SR) and incubated for 24 h. Cells transfected with the NF-B luciferase construct were also preincubated with DMSO or 10 M IKK␤ inhibitor (BMS345541, BMS) dissolved in DMSO for 1 h. Then, the cells were incubated with TGF-␤1 for 1 h, and the NF-B activity was determined. C, cells were pretreated with DMSO or 10 M MG132 dissolved in DMSO for 1 h and incubated with TGF-␤1 at 37°C. IB␣ and ␤-actin were analyzed by Western blotting. D, RAW 264.7 cells were co-transfected with the NF-B-luciferase reporter construct, pCS2ϩ-␤-galactosidase plasmids, and 1 g/ml mock vector (M) or an HA-tagged RhoA construct (WT, constitutively active (G14V), or dominant-negative (T19N)), incubated for 24 h, and then incubated with TGF-␤1 for 1 h. Luciferase activity was determined, and RhoA expression was assessed by Western blotting using an anti-HA antibody. E, cells were co-transfected with the NF-B-luciferase construct and pCS2ϩ-␤-galactosidase plasmids. After 24 h, the cells were incubated with 10 g/ml Tat-C3 for 1 h and then with TGF-␤1 for 1 h. The resulting luciferase activity was measured. F, cells were co-transfected with the NF-B-luciferase reporter construct, pCS2ϩ-␤-galactosidase plasmids, and either scrambled RNA (SCR) or 2 g/ml sh-RhoA plasmid (Sh). After 72 h, the cells were incubated with or without TGF-␤1 for 1 h, and then the luciferase activity was measured. G, cells were transfected with scrambled RNA or sh-RhoA and then stimulated with TGF-␤1. The phosphorylations of IB, IKK␣/␤, and p65 were analyzed by Western blotting. When the control value was set to 1, the amount of RhoA expressed in the presence of sh-RhoA was 0.33 Ϯ 0.058. The values represent the means Ϯ S.E. of three independent experiments (*, p Ͻ 0.05; **, p Ͻ 0.01; ***, p Ͻ 0.001).
directly phosphorylates Ser-177 and Ser-181 of IKK␤. Here, ROCK activity was demonstrated by measurement of the phosphorylation of myosin light chain phosphatase using anti-phospho-myosin light chain phosphatase antibody (Fig. 6D) . However, because TAK1 is required for NF-B activation (34), we examined the involvement of TAK1 in the regulation of the activation of RhoA. A TAK1 inhibitor, 5z-7-oxozeaenol, markedly abolished a TGF-␤1-dependent increase of RhoA-GTP levels (Fig. 6E) , suggesting that TAK1 is involved in RhoA activation upon TGF-␤1 stimulation.
NF-B Regulates Chemokine Expression-Finally, we observed that TGF-␤1 induced the transcription and protein expression of the chemokine such as MIP-1␣ (Fig. 7, A and B) and cell migration (Fig. 7C) . However, BMS-345541 (an inhibitor of IKK␤) inhibited the MIP-1␣ and cell migration, suggesting that NF-B activation is involved in the cell migration upon TGF-␤1 stimulation. Consistently, we recently reported that RhoA is required for the expression of MIP-1␣ upon TGF-␤1 stimulation (17, 22) .
DISCUSSION
Regulation of Transcription by RhoA-Rho proteins such as RhoA, Cdc42, and Rac1 regulate transcription via several transcription factors, including serum response factor (SRF), NF-B, and others regulated by the kinases such as JNK1 and p38 MAPK. The substrates of these kinases include Stat3, Stat5a, ELK, PEA3, ATF2, Max, and CHOP/GADD153 (35) . Among them, it has been well known that RhoA activates SRF (36) . The mechanism by which RhoA activates SRF has been proposed as follows; MAL/MKL1, a member of the myocardinrelated transcription factor (MRTF) is a cofactor of SRF that binds to monomeric G-actin in the cytosol but translocates to the nucleus after MAL is released from polymerized F-actin upon serum stimulation (37) . However, in this study, we disclosed that the activation of NF-B by RhoA is utterly different from SRF activation by RhoA.
RhoA-RhoGDI Complex Binds to IKK␥ Allowing RhoA Activation-Generally, IKK␥ provides binding sites for many proteins; 16 proteins have been reported as directly binding to IKK␥ and promoting the activation of NF-B (38) . Here, we presented that RhoA-GDP and RhoGDI are also bound to IKK␥; RhoA-GDP was bound to the N-terminal domain (aa and RhoGDI was bound to the large C-terminal domain (estimated aa 112-419) of IKK␥. The Rho-binding domain of IKK␥ is not identical with the known Rho-binding domains of effector proteins, including ROCK1, protein kinase N, rhophi- ) and phospho-myosin light chain phosphatase (p-MYPT) were identified with Western blotting. E, RAW264.7 cells were first pretreated with DMSO or 0.5 M 5z-7-oxozeaenol dissolved in DMSO for 1 h and then incubated with TGF-␤1 for 1 h. RhoA-GTP levels were determined using a GST-rhotekin-RBD pulldown assay. C, control; T, TGF-␤1. The data represent the means Ϯ S.E. of three independent experiments (*, p Ͻ 0.05; **, p Ͻ 0.01), and the means Ϯ range of two independent experiment for p-IKK ␣/␤ at Ser-176/177. lin, and rhotekin (supplemental Fig. S1 ). It is noteworthy that RhoA-GDP was also bound to small C-terminal domain (aa 351-419) of IKK␥, but not to the large C-terminal domain, suggesting that a part of C-terminal region (aa 101-350) interfere with RhoA-GDP binding to IKK␥. However, CC2 (coiled coil 2) and leucine zipper domains of IKK␥ (Fig. 3A) directly interact in an anti-parallel orientation through the connecting loop containing proline (39) , suggesting that N and C termini may be localized in the same direction (Fig. 3F) . Interestingly, IB binds to the C-terminal zinc finger domain (aa 389 -419) (28) , and IKK␤ binds to the N-terminal domain of IKK␥ (aa 44 -111) (29) . These results indicate that IKK␤ and IB bound to IKK␥ might be spatially close each other (Fig. 3F) . Indeed, IKK␤ itself interacts with the C terminus of IB forming a stable ternary complex with IKK␥ (40) . In addition, IB competes with RhoGDI for the binding to IKK␥ in vitro and in vivo upon TGF-␤1 (Fig. 3, C and D, respectively) . It remains unclear how the binding of IB to IKK␥ increases upon TGF-␤1 with the decrease of RhoGDI. However, RhoA-binding domain may be a relatively short length of N terminus (aa 1-43), which is not overlapped with the IKK␤-binding site of IKK␥ (aa 44 -111); therefore, RhoA-GDP did not compete with IKK␤ for the binding to IKK␥ (Fig. 3E) .
In conclusion, we here propose that IKK␥ likely functions to activate RhoA by serving as a scaffold protein to recruit the RhoA-RhoGDI complex. It was indeed known that IKK␥ recruits IB to IKK␤ as a scaffold protein, allowing IKK␤ to phosphorylate IB (28, 41) . Because RhoA-GDP complexed with RhoGDI is not directly activated by GEFs (5, 6), a specific GDF to disrupt RhoA-RhoGDI complex has been accepted to be required for the activation of RhoA. Herein, we demonstrated that IKK␥ could allow RhoA of RhoA-RhoGDI complex to be readily incorporated with GTP (Fig. 3) . Moreover, the Dbs, a GEF of RhoA, much enhanced GTP binding to the RhoA-RhoGDI complex in the presence of IKK␥ (Fig. 3) , suggesting that IKK␥ allows the GEF to recognize, access, or act on RhoA complexed with RhoGDI; IKK␥ may play a role as a GDF.
Depending on the signaling pathway, there may be diverse GDFs that activate RhoA by a variety of specific stimuli. Indeed, several GDFs, including ezrin/radixin/moesin, Etk/Bmx, and neurotrophin receptor p75 NTR , have been reported (6, 42, 43) . Given that there are several GDFs, it is likely that each GDF activates RhoA in a different particular signal pathway.
In addition to GDFs, modification of RhoGDI itself releases Rho GTPases from the RhoA-RhoGDI complex; phosphorylation of RhoGDI at Tyr-156 by Src alleviates its affinity for RhoA, Rac1, and Cdc42 (44) , and phosphorylation RhoGDI by PKC␣ leads to dissociation from RhoA (45) . Because IKK␥ can be also modified with proteins similar to ubiquitin (46), it is possible that a variety modification of RhoA, RhoGDI, or IKK␥ actually regulates to disrupt the RhoA-RhoGDI complex in response to several stimuli in vivo. Nonetheless, it is evident that in vitro system unmodified recombinant IKK␥ facilitates GTP-binding to RhoA complexed with recombinant RhoGDI without modification of these proteins by any other stimuli.
Although RhoA was reported to be activated by TGF-␤1 via a GEF, including Vav2 or Net1 (18, 47) , Lbc, which is also referred to as AKAP13, AKAP-Lbc, and ARHGEF13 (48) was recently reported to be associated with ␣-catulin, which is bound to IKK-␤ (49). It is likely that different types of GEFs in different cells may be involved in the activation of RhoA in response to TGF-␤1.
Active RhoA/ROCK Activates NF-B-Eventually, RhoA-GTP released from IKK␥ by TGF-␤1 was thought to activate ROCK. Indeed, active ROCK directly phosphorylated the recombinant GST-IKK␤ at Ser-177 and Ser-181 residues in vitro (Fig. 6C) . Although TGF-␤1 activates TAK1 (50) and only TAK1 is generally accepted as an IKK kinase in a canonical pathway (51, 52) , it remains unclear whether IKK is activated by an upstream kinase or autophosphorylation (53, 54) . Here, we demonstrated that TAK1 is involved in RhoA activation upon TGF-␤1 (Fig. 6E) . Because ROCK and TAK1 are involved in NF-B activation (Fig. 6B) , we examined whether ROCK regulates TAK1 activity in a positive feedback manner. However, Y27632, an inhibitor of ROCK, did not influence the phosphorylation of TAK1. Consistent with this observation, neither si-ROCK1 nor si-ROCK2 had an influence on the phosphorylation of TAK1 (data not shown). These results suggest that RhoA/ROCK does not promote TAK1 activity. Although it is still ambiguous that TAK1 and/or ROCK directly activate(s) IKK␤, we propose that ROCK is able to directly phosphorylate IKK␤ and TAK1 is instead involved in the activation of RhoA (Fig. 6E) . However, it remains to be studied in the future how TAK1 is involved in RhoA regulation in TGF-␤1 signaling. On the other hand, a long term treatment of TGF-␤1 inactivates RhoA (Fig. 1A ) through p190RhoGAP and cAMP/Epac/ ARAP3 activation (17, 22) . Subsequently, NF-B activation was also abolished by a long term treatment of TGF-␤1 (Fig. 5A) .
Thus, it is a very intriguing novel finding that IKK␥ facilitates RhoA activation, which in turn activates ROCK, leading to direct phosphorylation of IKK␤ and subsequent activation of NF-B. Conclusively, the RhoA and IKK complexes may regulate each other and form a positive feedback loop to activate NF-B. Thus, we proposed the scheme of the new regulatory mechanism of NF-B activation through RhoA activation in response to TGF-␤ (Fig. 7D) .
